These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12603815)

  • 1. Molecular changes in fetal Down syndrome brain.
    Engidawork E; Lubec G
    J Neurochem; 2003 Mar; 84(5):895-904. PubMed ID: 12603815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C21orf5, a human candidate gene for brain abnormalities and mental retardation in Down syndrome.
    Rachidi M; Lopes C; Delezoide AL; Delabar JM
    Cytogenet Genome Res; 2006; 112(1-2):16-22. PubMed ID: 16276086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The brain in Down syndrome.
    Seidl R; Cairns N; Lubec G
    J Neural Transm Suppl; 2001; (61):247-61. PubMed ID: 11771748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A quantitative assessment of gene expression (QAGE) reveals differential overexpression of DOPEY2, a candidate gene for mental retardation, in Down syndrome brain regions.
    Rachidi M; Delezoide AL; Delabar JM; Lopes C
    Int J Dev Neurosci; 2009 Jun; 27(4):393-8. PubMed ID: 19460634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The brain in Down syndrome (TRISOMY 21).
    Lubec G; Engidawork E
    J Neurol; 2002 Oct; 249(10):1347-56. PubMed ID: 12382149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comprehensive Analyses of Molecules with Altered Expression in the Brain of a Mouse Model of Down Syndrome for Identification of Pharmacotherapeutic Targets].
    Ishihara K
    Yakugaku Zasshi; 2017; 137(7):807-810. PubMed ID: 28674291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fetal Therapy for Down Syndrome: Report of Three Cases and a Review of the Literature.
    Baggot PJ; Baggot RM
    Issues Law Med; 2017; 32(1):31-41. PubMed ID: 29108162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondrial dysfunction and tau hyperphosphorylation in Ts1Cje, a mouse model for Down syndrome.
    Shukkur EA; Shimohata A; Akagi T; Yu W; Yamaguchi M; Murayama M; Chui D; Takeuchi T; Amano K; Subramhanya KH; Hashikawa T; Sago H; Epstein CJ; Takashima A; Yamakawa K
    Hum Mol Genet; 2006 Sep; 15(18):2752-62. PubMed ID: 16891409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurodevelopmental delay, motor abnormalities and cognitive deficits in transgenic mice overexpressing Dyrk1A (minibrain), a murine model of Down's syndrome.
    Altafaj X; Dierssen M; Baamonde C; Martí E; Visa J; Guimerà J; Oset M; González JR; Flórez J; Fillat C; Estivill X
    Hum Mol Genet; 2001 Sep; 10(18):1915-23. PubMed ID: 11555628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and cellular mechanisms elucidating neurocognitive basis of functional impairments associated with intellectual disability in Down syndrome.
    Rachidi M; Lopes C
    Am J Intellect Dev Disabil; 2010 Mar; 115(2):83-112. PubMed ID: 20441388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of phenotypic abnormalities of Down syndrome with an imbalance of genes on chromosome 21.
    Becker LE; Mito T; Takashima S; Onodera K; Friend WC
    APMIS Suppl; 1993; 40():57-70. PubMed ID: 8311992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of DSCR1 to disomy in the trisomy 16 mouse model of Down syndrome does not correct cardiac or craniofacial development anomalies.
    Lange AW; Rothermel BA; Yutzey KE
    Dev Dyn; 2005 Jul; 233(3):954-63. PubMed ID: 15906378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth and development of the brain in Down syndrome.
    Becker L; Mito T; Takashima S; Onodera K
    Prog Clin Biol Res; 1991; 373():133-52. PubMed ID: 1838182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein levels of genes encoded on chromosome 21 in fetal Down syndrome brain: challenging the gene dosage effect hypothesis (Part II).
    Cheon MS; Bajo M; Kim SH; Claudio JO; Stewart AK; Patterson D; Kruger WD; Kondoh H; Lubec G
    Amino Acids; 2003; 24(1-2):119-25. PubMed ID: 12624743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developmental defects in trisomy 21 and mouse models.
    Delabar JM; Aflalo-Rattenbac R; Créau N
    ScientificWorldJournal; 2006 Sep; 6():1945-64. PubMed ID: 17205199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlates of mental retardation and structural changes of the brain.
    Shaw CM
    Brain Dev; 1987; 9(1):1-8. PubMed ID: 2955713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of Prenatal Forebrain Defects in the Dp(16)1Yey/+ Mouse Model of Down Syndrome.
    Goodliffe JW; Olmos-Serrano JL; Aziz NM; Pennings JL; Guedj F; Bianchi DW; Haydar TF
    J Neurosci; 2016 Mar; 36(10):2926-44. PubMed ID: 26961948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for apoptosis in the fetal Down syndrome brain.
    Seidl R; Bidmon B; Bajo M; Yoo PC; Cairns N; LaCasse EC; Lubec G
    J Child Neurol; 2001 Jun; 16(6):438-42. PubMed ID: 11417611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A gel-based proteomic method reveals several protein pathway abnormalities in fetal Down syndrome brain.
    Sun Y; Dierssen M; Toran N; Pollak DD; Chen WQ; Lubec G
    J Proteomics; 2011 Apr; 74(4):547-57. PubMed ID: 21262400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Four cases of fetal hypoechoic hepatomegaly associated with Trisomy 21 and transient abnormal myelopoiesis.
    Kikuchi A; Tamura N; Ishii K; Takakuwa K; Matsunaga M; Sudo N; Tanaka K
    Prenat Diagn; 2007 Jul; 27(7):665-9. PubMed ID: 17437323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.